33
Participants
Start Date
August 4, 2023
Primary Completion Date
August 23, 2024
Study Completion Date
August 23, 2024
BAG Freiberg-Richter, Jacobash, Illmer, Wolf, Dresden
Klinikum Chemnitz Ggmbh, Chemnitz
Onkologische Schwerpunktpraxis Dres. Ingo Zander und Eyck von der Heyde, Hanover
Klinikum Kassel, Kassel
Universitätsklinik Magdeburg, Magdeburg
University Of Louisville, Louisville
Alexianer, Maria-Hilf-Krankenhaus, Essen
Oncologianova GmbH, Recklinghausen
Universitätsklinikum Bonn, Bonn
Local Institution - 0006, Mainz
CaritasKlinikum Saarbruecken., Saarbrücken
Local Institution - 0033, Homburg
Universitätsklinikum Tübingen, Tübingen
Klinikum Munchen-Bogenhausen, München
University of Alabama at Birmingham, Birmingham
Pacific Central Coast Health Centers - San Luis Obispo Oncology and Hematology Health Center, San Luis Obispo
Mission Cancer Center, Santa Maria
Saint Alphonsus Regional Medical Center, Boise
UPMC Hillman Cancer Center, Westwood
Weill Cornell Medical College, New York
Local Institution - 0009, Dallas
William Beaumont Army Medical Center, Fort Bliss
The University Of Texas, Houston
Baylor Scott and White Health, Temple
Lead Sponsor
Collaborators (1)
PPD Development, LP
INDUSTRY
Bristol-Myers Squibb
INDUSTRY